Cutaneous relapse of angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma mimicking an exanthematous drug eruption

International Journal of Dermatology

Volumn 42, Issue 10, 2003, Pages 816-818

  Yoon, Ghil Suk ^a,b   Chang, Sung Eun ^a,b   Kim, Huyng Hoon ^a,b   Choi, Jee Ho ^a,b   Sung, Kyoung Jeh ^a,b   Moon, Kee Chan ^a,b  

^a Catholic University of Daegu   (South Korea)

^b University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PREDNISOLONE; VINCRISTINE;

ADULT; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; AUTOIMMUNE HEMOLYTIC ANEMIA; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CUTANEOUS T CELL LYMPHOMA; DRUG ERUPTION; DRUG RESPONSE; FEVER; HEPATOSPLENOMEGALY; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION; KOREA; LABORATORY TEST; LYMPH NODE BIOPSY; LYMPHOCYTOSIS; MALE; MUSCLE WEAKNESS; PERIPHERAL T CELL LYMPHOMA; PHYSICAL EXAMINATION; PROPHYLAXIS; SYSTEMIC THERAPY; TREATMENT FAILURE;

DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; HUMANS; IMMUNOBLASTIC LYMPHADENOPATHY; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SKIN;

EID: 0142186788     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01721.x     Document Type: Conference Paper

References (9)

1. Martel P, Laroche L, Courville P, et al. Cutaneous involvement in patients with angioimmunoblastic lymphadenopathy with dysproteinemia: A clinical, immunohistological, and molecular analysis. Arch Dermatol 2000; 136: 881-886.
2. Takai K, Sanada M. Angioimmunoblastic T-cell lymphoma associated with hemophagocytic syndrome at onset and relapse. Rinsho Ketsueki 2000; 41: 1260-1266.
3. Attygalle A, Al-Jehani R, Diss TC, et al. Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 2002; 99: 627-633.
4. Armitage JO, Weissenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. J Clin Oncol 1998; 16: 2780-2795.
5. Willenbrock K, Roers A, Seidl C, et al. Analysis of T-cell subpopulations in T-cell non-Hodgkin's lymphoma of angioimmunoblastic lymphadenopathy with dysproteinemia type by single target gene amplification of T cell receptor-beta gene rearrangements. Am J Pathol 2001; 158: 1851-1857.
6. Murakami T, Ohtsuki M, Nakagawa H. Angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma with cutaneous infiltration: Report of a case and its gene expression profile. Br J Dermatol 2001; 144: 878-884.
7. Djerbi M, Screpani V, Catrina AI, et al. The inhibition of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med 1999; 190: 1025-1032.
8. Gerlando Q, Barbera V, Ammatuna E, et al. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma by combined methotrexate and prednisone. Haematologica 2000; 85: 880-881.
9. Tsatalas C, Margaritis D, Kaloutsi V, et al. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine. Acta Haematol 2001; 105: 106-108.